Department of General Surgery, Wexham Park Hospital, Slough SL2 4HI, UK
Correspondence to: Miss Sisse Olsen, Department of Surgical Oncology and
Technology, 10th Floor OEQM Wing, St Mary's Hospital, London W2 1NY,
UK
E-mail:
s.olsen{at}ic.ac.uk
Cytomegalovirus infection can complicate Crohn's colitis. Early detection and diagnosis is important in relation to treatment.
CASE HISTORY
A man of 70 was seen at the colorectal outpatient clinic after a month of diarrhoea, weight loss, anaemia and rectal bleeding. He was admitted, and on flexible sigmoidoscopy he was found to have extensive severe colitis with ulceration and pseudopolyposis but rectal sparing. Microscopy revealed deep fissuring ulcers and inflammatory infiltrate but no cryptitis, crypt abscesses or granulomas. There was no evidence of superimposed infection, dysplasia or malignancy. Crohn's colitis was diagnosed and he responded well to intravenous hydrocortisone 100 mg three times daily and mesalazine 400 mg three times daily. He was admitted subsequently with a relapse which responded to steroid therapy.
Six weeks after his second discharge he attended the accident and emergency department because of diarrhoea, anaemia and weight loss. Admitted under the care of the medical team he was treated for two weeks with oral prednisolone 30 mg daily and mesalazine. Clinically he deteriorated, with a rise in C-reactive protein and a fall in haemoglobin, white blood cell count and albumin. On day 14 he was reviewed by the gastroenterology team and the treatment was changed to intravenous hydrocortisone 100 mg three times daily; the mesalazine was stopped. On day 16 the colorectal team took over his care. Despite high-dose immunosuppressive treatment he continued to deteriorate and was transferred to the high dependency unit for correction of refractory hypokalaemia. On day 24, colonoscopy revealed severe active colitis to the ascending colon; multiple biopsies were taken. 3 days later, because of further clinical deterioration, he underwent subtotal colectomy with end ileostomy and cutaneous mucous fistula of the rectum. On the day after the operation, a report on the colonoscopic biopsies became available. As before, the findings were consistent with Crohn's colitis with relative preservation of mucosal architecture, but unexpectedly there was evidence of cytomegalovirus infection in the form of multiple large cells with eccentric nuclei surrounded by a clear halo and viral inclusion bodies in the cytoplasm (Figure 1). Rectal biopsies a year later revealed Crohn's colitis but no cytomegalovirus infection.
|
COMMENT
Cytomegalovirus infection can complicate both ulcerative colitis and Crohn's disease. The virus belongs to the herpes virus family and 40-100%1 of the adult population have been infected. Most infections are subclinical and lead to lifelong latency. However, in immunocompromised individuals such as transplant recipients and AIDS patients, the virus can cause severe disease. A connection has been suspected between cytomegalovirus inclusion disease and ulcerative colitis since 1961.2 The prevalence of cytomegalovirus complicated colitis in patients with inflammatory bowel disease has been estimated at 0.53-4%,3-4 but in patients presenting with severe steroid refractive Crohn's disease it is thought to be much higher at 11-36%.5 Clinical pointers to viral complications include persistent severe hypokalaemia, high spiking pyrexia, lymphadenopathy and bone marrow suppression3 but such features are seen also in patients with uncomplicated severe steroid-resistant Crohn's colitis. The recommended means of diagnosis is histological examination of biopsies from the affected mucosa and ulcer beds.3,5-6 Serological tests and virus isolation from blood or faeces do not prove colonic infection.
With earlier diagnosis the present patient might have been spared surgery. When cytomegalovirus infection is found to be complicating Crohn's colitis, steroid treatment should be reduced, other immunomodulatory treatments stopped, and ganciclovir 10-15 mg/kg daily in divided doses given for 2-3 weeks.3,6 Such treatment has reduced emergency colectomy rates from 80% to 33% and case fatality from 33% to 5% in patients with severe steroid-refractory inflammatory bowel disease complicated by cytomegalovirus infection. However, about one-fifth of patients so treated need colectomy within three months because the underlying bowel disease has become reactivated or the viral infection has persisted.6
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||